Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE
Conditions: Antiphospholipid Syndrome; Ischemic Stroke; Transient Ischemic Attack; Cerebrovascular Disease; Cardiovascular Diseases; Major Bleed Interventions: Drug: Antiplatelet Drug; Drug: Warfarin Sponsors: Seoul National University Hospital; Samjin Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2023 Category: Research Source Type: clinical trials
Ticagrelor Versus Clopidogrel for CMD in Patients With AMI: A Retrospective Study Based on the Angio-IMR
Condition: Coronary Heart Disease Intervention: Drug: Dual antiplatelet therapy with aspirin and either ticagrelor or clopidogrel Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2023 Category: Research Source Type: clinical trials
